Theorem Clinical Research

Technology Solutions

Evolution Scientific joins SAFE-BioPharma

Friday, February 28, 2014 12:05 PM

Evolution Scientific (ESi), a technical service provider to the pharmaceutical, biotech, medical device and other regulated industries, has joined SAFE-BioPharma Association, the nonprofit industry coalition responsible for the ongoing development and implementation of the SAFE-BioPharma digital identity and signature standard.

More... »


Charles River Laboratories is first CRO to join Exostar Life Science Identity Hub

Friday, February 28, 2014 12:01 PM

Charles River Laboratories is the first CRO to join Exostar’s rapidly growing life sciences community, which currently includes numerous CROs among the more than 500 organizations and 10,000 individuals in almost 50 countries worldwide.  The Exostar Life Sciences Identity Hub brings CROs, pharmaceutical manufacturers and academic institutions together to facilitate secure collaboration, reduce capital and operating expenditures and drive revenue by enhancing productivity and speeding time-to-market.

More... »


AG Mednet, Cardialysis partner for efficient cardiovascular clinical trials

Friday, February 28, 2014 12:00 PM

Cardialysis, an independent CRO, has selected AG Mednet, a quality compliance company, as preferred provider for image data submission and collection.

More... »

BBK Worldwide launches Bio Notifier Plus

Friday, February 28, 2014 11:57 AM

BBK Worldwide, a provider of patient recruitment, has launched BIO Notifier Plus, which utilizes a global opt-in physician database, a proprietary rating and ranking system and in-country direct physician contact to bring specialists to clinical trials.

More... »

Novartis, Janssen, Eli Lilly, Aptiv Solutions co-found new consortium

Friday, February 21, 2014 11:05 AM

Aptiv Solutions, a global biopharmaceutical and medical device development services company, Novartis Pharma, Janssen Pharmaceuticals and Eli Lilly have joined in co-founding the ADDPLAN DF Consortium. The members of the consortium are collaboratively developing new statistical methodologies for the design of innovative dose-finding clinical trials, with an emphasis on adaptive designs. The ADDPLAN DF Consortium also will focus on enhancing the trial execution technologies required to handle the multiple adaptations integral to complex adaptive dose-finding trials. Aptiv Solutions will integrate and validate the methodologies that emerge from the ADDPLAN DF Consortium into its ADDPLAN DF software for the design, planning and analysis of dose finding trials, in addition to ensuring that these designs can be easily implemented through its proprietary execution platform.

More... »

ADA Medical now offering preclinical imaging services

Wednesday, February 19, 2014 01:17 PM

ADA Medical, a Research Partnership Group of research professionals dedicated to the successful implementation and completion of clinical research projects for the pharmaceutical, biotechnology and medical device industries, is collaborating with CRO Ephoran Multi-Imaging Solutions.

More... »

Illumina launches the Illumina Accelerator Program

Friday, February 14, 2014 01:52 PM

Illumina, a developer, manufacturer and marketer of life science tools and integrated systems for the analysis of genetic variation and function, has launched the Illumina Accelerator Program, the world's first business accelerator focused solely on creating an innovation ecosystem for the genomics industry. Its goal is to speed the time to market and lower the barriers to entry for entrepreneurs, startups and early stage companies working on scientifically and commercially promising next-generation sequencing (NGS) applications.

More... »

BioClinica sees eClinical growth in Europe

Friday, February 14, 2014 01:45 PM

BioClinica, a global provider of clinical trial management solutions, has announced that Europe was the fastest growing geographic region in 2013 for its eClinical technology products. The company plans continued investments in its European workforce in of operations and sales, potentially doubling its European eClinical presence in 2014.

More... »

Report: U.S. Alzheimer's imaging agent market will grow as reimbursement improves

Thursday, February 13, 2014 03:03 PM

The U.S. Alzheimer's imaging agent market will grow dramatically over the next 10 years, according to Decision Resources Group. Currently, Eli Lilly's Amyvid, launched in June 2013, is the only FDA-approved product available, but GE Healthcare, Piramal Enterprises and Navidea Biopharmaceuticalsare all poised to launch products in the U.S. in the next few years.

More... »

Translational Imaging Center to speed drug development, lower costs

Thursday, February 13, 2014 02:36 PM

MPI Research, inviCRO and 3D Imaging have formally announced the name of their new advanced imaging center being built at the MPI Research headquarters in Mattawan, Mich. A joint partnership by the three organizations, the Translational Imaging Center is the first resource for the drug development community to combine molecular imaging and autoradiography with an onsite cyclotron, vivarium and advanced image analytics.

More... »

Subscribe to The CenterWatch Monthly
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

October 20

Toronto Star, with FDA data, exposes weaknesses in Health Canada's clinical trial, inspection oversight

Crowdsourcing effort aims to fund updated online social media guide for sponsor interaction with patients

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

September

Today's fastest, most economical sponsors
Standout sponsors reveal how they shorten regulatory, clinical cycle times

From the trenches: Sites' eye view of state of the industry
CW’s first site focus groups uncover frustration with 'progress,' but a passion for their mission

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs